Retension Pharmaceuticals Names Robert Wong Chief Accounting Officer

• Retension Pharmaceuticals appointed Robert Wong vice president and chief accounting officer on October 21, 2026, effective November 2, 2026.
• Wong most recently served as vice president of accounting at The Save Mart Companies, overseeing accounting, finance, tax and treasury.
• He previously served as Cytokinetics’ vice president and chief accounting officer from 2019 to 2024.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Retension Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-111794), on October 23, 2026, and is solely responsible for the information contained therein.